Indian Journal of Clinical Biochemistry

, Volume 25, Issue 4, pp 388–392 | Cite as

Role of Oxidative Stress in Various Stages of Psoriasis

  • Dipali P. KadamEmail author
  • Adinath N. Suryakar
  • Rajesh D. Ankush
  • Charushila Y. Kadam
  • Kishor H. Deshpande
Original Article


Psoriasis is a chronic inflammatory, proliferative skin disease characterized by pathological skin lesions due to various exogenous and endogenous factors. It is associated with a number of biochemical and immunological disturbances. Recently, it has been suggested that increased reactive oxygen species (ROS) production and compromised function of antioxidant system may be involved in the pathogenesis of this disease. In the present study, 90 psoriasis patients were selected. Disease severity was assessed by psoriasis area severity index score and grouped as mild, moderate and severe (each group consists of 30 subjects) and compared with 30 healthy controls. Serum levels of malondialdehyde, nitric oxide end products and the activities of antioxidant enzymes such as erythrocyte-superoxide dismutase, catalase and total antioxidant status were investigated in these groups/subjects. As compared to controls, we found severitywise significantly increased serum malondialdehyde, nitric oxide end products with decrease in erythrocyte-superoxide dismutase activity, catalase activity and total antioxidant status in patients with psoriasis suggesting worsening of the disease. It seems to be linked with the enhancement of Reactive Oxygen Species production and decreased antioxidant potential in psoriasis.


Psoriasis Lipid peroxidation Total antioxidant status Oxidative stress Enzymatic antioxidants 


  1. 1.
    Wozniak A, Drewa G, Krzyzynka-Malinowska E, Czajkowski R, Protas-Drozd F, Mila-Kierzenkowska C, et al. Oxidant antioxidant balance in patients with psoriasis. Med Sci Monit. 2007;13(1):R 30–3.Google Scholar
  2. 2.
    Vanizor KB, Orem A, Cimsit G, Yandi YE, Calapoglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationship with oxidant–antioxidant system in patients with psoriasis. Clin Chim Acta. 2003;328(1–2):71–82.CrossRefGoogle Scholar
  3. 3.
    Luty-Frackiwicz A, Gorka IM, Januszewska L. Influence of smoking and alcohol consumption on total antioxidant status in patients with psoriasis. Adv Clin Exp Med. 2006;15(3):463–9.Google Scholar
  4. 4.
    Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002;29:399–403.PubMedGoogle Scholar
  5. 5.
    Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases—what’s new? JEADV. 2003;17:663–9.PubMedGoogle Scholar
  6. 6.
    Corrocher R, Ferrari S, Gironcoli M, Bassi A, Olivieri O, Guarini P, et al. Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis. Clin Chim Acta. 1989;179:121–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Cals-Grierson MM, Ormerod AD. Nitric oxide functions in the skin. Nitric Oxide. 2004;10(4):179–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antoxidants in epidermis and dermis of human skin. J Investig Dermatol. 1994;102:122–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Langseth L. Oxidants, antioxidants and disease prevention. International Life Sciences Institute and ILSI Europe; 1995. p. 1–32.Google Scholar
  10. 10.
    Baz K, Cimen MYB, Kokturk A, Yazici AC, Eskandari G, Ikizoglu G, et al. Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J. 2003;44(6):987–90.PubMedGoogle Scholar
  11. 11.
    Louden BA, Pearce DJ, Lang W, Feldman SR. A simplified psoriasis area severity index (SPASI) for rating psoriasis severity in clinical patients. Dermatol Online J. 2004;10(2):7.PubMedGoogle Scholar
  12. 12.
    Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.CrossRefPubMedGoogle Scholar
  13. 13.
    Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium reduction method. Clin Chem. 1990;36(8):1440–3.PubMedGoogle Scholar
  14. 14.
    Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196:143–52.CrossRefPubMedGoogle Scholar
  15. 15.
    Das K, Samanta L, Chainy GBN. A modified spectrophotometric assay of superoxide dismutase using nitrite formation by superoxide radicals. Indian J Biochem Biophys. 2000;37:201–4.Google Scholar
  16. 16.
    Benzie IFF, Strain JJ. The ferric reducing ability of plasma [FRAP] as a measure of ‘antioxidant power’ the FRAP assay. Anal Biochem. 1996;239:70–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta. 2007;380:50–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Yildirim M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. JEADV. 2003;17:34–6.PubMedGoogle Scholar
  19. 19.
    Popov I, Lewin G. A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses. 1991;35:229–36.CrossRefPubMedGoogle Scholar
  20. 20.
    Miyachi Y, Niwa Y. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes. Arch Dermatol Res. 1983;275:23–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Turner CP, Toye AM, Jones OTG. Keratinocyte superoxide generation. Free Radic Biol Med. 1998;24(3):401–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Raynaud F, Evain-Brion D, Gerbaud P, Marciano D, Gorin I, Liapi C, et al. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Radic Biol Med. 1996;22(4):623–32.CrossRefGoogle Scholar
  23. 23.
    Hristakieva E, Gadjeva V. Seasonal variations in the activity of antioxidant enzymes and lipid peroxidation in psoriatic and vitiligo patients. Trakia J Sci. 2003;1(1):27–31.Google Scholar
  24. 24.
    Dimon-Gadal S, Gerbaud P, Therond P, Guibourdenche J, Anderson WB, Evain-Brion D, et al. Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J Investig Dermatol. 2000;114:984–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Tekin NS, Ilter N, Sancak B, Ozden MG, Gurer MA. Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediat Inflamm. 2006;16043l:1–5.CrossRefGoogle Scholar
  26. 26.
    Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998;41(7):1141–51.CrossRefPubMedGoogle Scholar
  27. 27.
    Kolb-Bachofen V, Fehsel K, Michel G, Ruzicka T. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of Psoriasis vulgaris. Lancet. 1994;344:139.CrossRefPubMedGoogle Scholar
  28. 28.
    Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowksi P, et al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res. 1998;290:3–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Sirsjo A, Karlsson M, Gidof A, Rollman O, Torma H. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol. 1996;134(4):643–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Orem A, Aliyazicioglu R, Kiran E, Vanizor B, Cimnocodeit G, Deger O. The relationship between nitric oxide production and activity of the disease in patients with psoriasis. Arch Dermatol. 1997;133:1606–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Ilzuka H, Asaga H, Koike K, Ilzuka S. Decreased Cu, Zn-superoxide dismutase activity in psoriatic hyperproliferative epidermis. Eur J Dermatol. 1993;3:56–8.Google Scholar
  32. 32.
    Kobayashi T, Matsumoto M, Ilzuka H, Suzuki K, Taniguchi N. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: an immunohistochemical study. Br J Dermatol. 1991;124(6):555–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Gornicki A, Gutsze A. Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J Dermatol Sci. 2001;27:27–30.CrossRefPubMedGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2010

Authors and Affiliations

  • Dipali P. Kadam
    • 1
    Email author
  • Adinath N. Suryakar
    • 1
  • Rajesh D. Ankush
    • 1
  • Charushila Y. Kadam
    • 1
  • Kishor H. Deshpande
    • 1
  1. 1.Department of BiochemistryDr. V. M. Govt. Medical CollegeSolapurIndia

Personalised recommendations